English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/5049
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Peroxisome-proliferator-activated receptor a agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1

AuthorsGrau, Raquel; Punzón, Carmen ; Fresno, Manuel ; Íñiguez, Miguel Ángel
KeywordsPeroxisome-proliferator-activated receptor a (PPARa)
Cyclo-oxygenase 2 (COX-2)
LY-171883
SW620 cell
Vascular endothelial growth factor (VEGF)
WY-14,643
Issue Date13-Dec-2005
PublisherPortland Press
CitationBiochem. J. (2006) 395 (81–88)
AbstractRecent evidence indicates that PPAR (peroxisome-proliferator-activated receptor) a ligands possess anti-inflammatory and antitumoural properties owing to their inhibitory effects on the expression of genes that are involved in the inflammatory response. However, the precise molecular mechanisms underlying these effects are poorly understood. In the present study, we show that tumour promoter PMA-mediated induction of genes that are significantly associated with inflammation, tumour growth and metastasis, such as COX-2 (cyclo-oxygenase 2) and VEGF (vascular endothelial growth factor), is inhibited by PPARa ligands in the human colorectal carcinoma cell line SW620. PPARa activators LY-171883 and WY-14,643 were able to diminish transcriptional induction of COX-2 and VEGF by inhibiting AP-1 (activator protein-1)-mediated transcriptional activation induced by PMA or by c-Jun overexpression. The actions of these ligands on AP-1 activation and COX-2 and VEGF transcriptional induction were found to be dependent on PPARa expression. Our studies demonstrate the existence of a negative cross-talk between the PPARa- and AP-1-dependent signalling pathways in these cells. PPARa interfered with at least two steps within the pathway leading to AP-1 activation. First, PPARa activation impaired AP-1 binding to a consensus DNA sequence. Secondly, PPARa ligands inhibited c-Jun transactivating activity. Taken together, these findings provide new insight into the anti-inflammatory and anti-tumoural properties of PPARa activation, through the inhibition of the induction of AP-1-dependent genes that are involved in inflammation and tumour progression
DescriptionArticle available at http://dx.doi.org/10.1042/BJ20050964
URIhttp://hdl.handle.net/10261/5049
ISSN0264-6021
E-ISSN1470-8728
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
MAIñiguez_BiochemJ_81.pdf372,9 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.